The COVID-19 pandemic rages on, with no clear end in sight. There is some eventual promise of safe and effective vaccines, but the timetable for their distribution is not yet known. Therefore, we face ...

An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...

This article originally appeared on ProPublica. In the first 18 months of the COVID-19 pandemic, tens of thousands of pregnant women were wheeled into hospitals where they fought for their lives and ...

Medicine can help people who are at risk of, diagnosed with, or have symptoms of COVID-19.

Though COVID-19 isn’t the global health emergency it once was, it remains a critical issue that requires ongoing attention.¹ More than 37,000 COVID-19–related deaths were reported in the United States ...

This fall, a federal vaccine advisory panel changed recommendations, saying Americans six months and older should discuss the risks and benefits with their health care providers. The move walked back ...

Wastewater signals show BA.3.2 across 25 states, while NWSS funding reductions threaten program continuity after FY2025, diminishing national situational awareness for emerging variants. Genomic ...

National Poll on Healthy Aging data from adults age 50 and over who replied to a poll in late December 2025 and early January 2026 saying that they had not received a flu vaccination in the last 6 ...

Children are twice as likely to develop long COVID after two COVID-19 infections, compared with children who’ve only had COVID-19 once, according to a new study co-authored by a doctor at Lurie ...